Answers are grounded in this paper and cite their sources.
Randomised trial demonstrates reduced inflammation in type 2 diabetes patients after exercise prescriptions, suggesting baseline insulin resistance influences outcomes.
Purpose To examine how baseline insulin resistance (IR) modulates exercise-induced changes in systemic immune-inflammation index (SII) and metabolic parameters in type 2 diabetes mellitus (T2DM). Methods Fifty-five T2DM patients stratified by fasting C-peptide tertiles into low- (Group 1), moderate- (Group 2), and high-IR groups (Group 3) completed a 4-week moderate-intensity combined aerobic-resistance exercise program. Changes in SII (neutrophils × platelets/lymphocytes), anthropometrics, and glucolipid markers were assessed, with ANCOVA and hierarchical regression modeling intergroup differences and predictors (Clinical Trial Registration ID: ChiCTR2200066710). Results Significant reductions in weight, BMI, and body fat% occurred in Group 1/Group 2 (all p <0.05) but not Group 3. SII decreased in Group 1 ( p <0.05) yet increased in Group 3 due to neutrophil elevation ( p <0.05). Fasting glucose and HbA1c improved across all groups ( p <0.05), with Group 3’s glycemic benefits independent of weight loss or anti-inflammatory effects. Baseline C-peptide independently predicted increases in ΔSII across all adjusted models (β=19.85–21.94, p <0.01), whereas covariates including age, diabetes duration, and BMI showed no significant effects. Conclusion Severe baseline IR attenuates exercise-mediated SII improvement and body composition optimization, whereas glycemic benefits remain IR-independent, necessitating IR-stratified exercise prescriptions. Clinical trial registration Chinese Clinical Trial Registry, identifier ChiCTR2200066710.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: